StockClub
DNTHDianthus Therapeutics, Inc.$ --
Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

DNTH

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2025 Q4Updated: 12/31/2025

Revenue

attach_money
0M USD
-

Operating Income

trending_up
-70M USD
-

Net Income

verified
98M USD
-

EPS

paid
2.59$
-

Revenue

$284,000

MISS
$806,900
$1.2M
Q1
$858,200
$193,000
Q2
$576,000
$396,000
Q3
$552,231
$284,000
Q4
$2.8M
$2M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Net Income

$97.9M

BEAT
$-32.1M
$-29.5M
Q1
$-32.9M
$-31.6M
Q2
$-32.8M
$-36.8M
Q3
$-38M
$97.9M
Q4
$-135.9M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Surprise History

ActualEstimate
FY2025MISS
$2M

Future Forecast